These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8171215)

  • 1. Genital herpes: therapeutic implications.
    D'Anna A; Ghavehchi Khaligh D; Dattino M; D'Anna A
    Riv Eur Sci Med Farmacol; 1993; 15(2):107-9. PubMed ID: 8171215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of oral acyclovir in the management of genital herpes simplex.
    Sacks SL
    CMAJ; 1987 Apr; 136(7):701-7. PubMed ID: 3548933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valacyclovir for the treatment of genital herpes.
    Brantley JS; Hicks L; Sra K; Tyring SK
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):367-76. PubMed ID: 16771614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
    Handsfield HH; Warren T; Werner M; Phillips JA
    Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Audit of the management of genital herpes simplex infection.
    Matin RN; Brady M; Poulton M
    Int J STD AIDS; 2006 Dec; 17(12):851-3. PubMed ID: 17212865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term suppressive therapy with acyclovir for recurrent genital herpes.
    Baker DA
    J Int Med Res; 1994; 22 Suppl 1():24A-31A; discussion 31A-32A. PubMed ID: 8063021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genital herpes--when and how to treat.
    Kroon S
    Semin Dermatol; 1990 Jun; 9(2):133-40. PubMed ID: 2202409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment to prevent recurrent genital herpes.
    Martinez V; Caumes E; Chosidow O
    Curr Opin Infect Dis; 2008 Feb; 21(1):42-8. PubMed ID: 18192785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
    Wald A; Carrell D; Remington M; Kexel E; Zeh J; Corey L
    Clin Infect Dis; 2002 Apr; 34(7):944-8. PubMed ID: 11880960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.
    Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD
    Infect Dis Obstet Gynecol; 2001; 9(2):75-80. PubMed ID: 11495557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of recurrent genital herpes with oral acyclovir.
    Salo OP
    Scand J Infect Dis Suppl; 1985; 47():67-9. PubMed ID: 3868026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyclovir suppression to prevent recurrent genital herpes at delivery.
    Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD
    Infect Dis Obstet Gynecol; 2002; 10(2):71-7. PubMed ID: 12530483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the risk of transmitting genital herpes: advances in understanding and therapy.
    Leone P
    Curr Med Res Opin; 2005 Oct; 21(10):1577-82. PubMed ID: 16238897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of genital herpes in HIV-infected patients.
    Aoki FY
    Herpes; 2001 Jul; 8(2):41-5. PubMed ID: 11867017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of herpes simplex virus type 2 transmission with antiviral therapy.
    Corey L; Ashley R;
    Herpes; 2004 Aug; 11 Suppl 3():170A-174A. PubMed ID: 15319087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment trials of the therapeutic efficacy of the drug "Zovirax" in some recurrent ocular and genital herpetic infections.
    Muţiu A; Sahnazarov N; Crişan I
    Rom J Virol; 1998; 49(1-4):27-42. PubMed ID: 10892424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on short-course episodic and prevention therapies for herpes genitalis.
    Corey L; Bodsworth N; Mindel A; Patel R; Schacker T; Stanberry L
    Herpes; 2007 Jun; 14 Suppl 1():5A-11A. PubMed ID: 17877886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
    Warren T; Harris J; Brennan CA
    Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does frequency of genital herpes recurrences predict risk of transmission? Further analysis of the valacyclovir transmission study.
    Kim HN; Wald A; Harris J; Almekinder J; Heitman C; Corey L
    Sex Transm Dis; 2008 Feb; 35(2):124-8. PubMed ID: 17921912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.